Search Results 301-310 of 17253 for GLP-1 therapy

1. Hormone Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

   ... treatment with at least one line of endocrine therapy. The objectives of the study are to first identify, in open-label single-arm Phase I, a recommended ...

2. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic researchers found that a sugar molecule on cancer cells may eventually be useful in the treatment of type 1 diabetes. Latest stories. Science ...

3. Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer - Mayo Clinic

   Investigation of Ubamatamab Combination Therapy ... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long-term safety ...

4. Neurosurgery - Clinical trials

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

5. Brain Tumor Program - Clinical trials

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

6. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   - History of type 1 diabetes. - Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the period from 90 days prior to the screening visit ...

7. Ivosidenib In Participants With Locally Advanced Or Metastatic Conventional Chondrosarcoma Untreated Or Previously Treated With 1 Systemic Treatment Regimen - Mayo Clinic

   1) and have received 0 to 1 prior systemic treatment regimen in the advanced/metastatic setting for conventional chondrosarcoma. The primary endpoint is ...

8. Study of SBP-101 in Pancreatic Cancer - Mayo Clinic

   Received and failed, or were intolerant to, at least 1 prior systemic therapy for locally advanced or metastatic pancreatic ductal adenocarcinoma. Adult, at ...

9. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

   ... treatment works better than the current standard therapy. They also ... treatment (Weeks 1-5). Subjects may renew the use of the above at week 6 ...

10. Functional dyspepsia - Diagnosis and treatment - Mayo Clinic

    Behavior therapy. Working with a counselor or ... Together, they relieved pain symptoms in a one-week trial. ... A placebo is a treatment with no therapeutic ...